Wolfgang Oertel, Professor - Publications

Affiliations: 
Neurology Marburg university 

103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Meles SK, Oertel WH, Leenders KL. Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease. Molecular Medicine (Cambridge, Mass.). 27: 111. PMID 34530732 DOI: 10.1186/s10020-021-00327-x  1
2021 Miglis MG, Adler CH, Antelmi E, Arnaldi D, Baldelli L, Boeve BF, Cesari M, Dall'Antonia I, Diederich NJ, Doppler K, Dušek P, Ferri R, Gagnon JF, Gan-Or Z, Hermann W, ... ... Oertel WH, et al. Biomarkers of conversion to α-synucleinopathy in isolated rapid-eye-movement sleep behaviour disorder. The Lancet. Neurology. 20: 671-684. PMID 34302789 DOI: 10.1016/S1474-4422(21)00176-9  1
2021 Fields T, Schoser B, Oertel W, Strupp M. Acetyl-DL-leucine improves restless legs syndrome: a case report. Journal of Neurology. PMID 34052888 DOI: 10.1007/s00415-021-10625-3  0.01
2021 Sayegh ALC, Janzen A, Strzedulla I, Birklein F, Lautenschläger G, Oertel WH, Krämer HH, Best C. Increased muscle sympathetic nerve activity and impaired baroreflex control in isolated REM-sleep behavior disorder. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 132: 1537-1542. PMID 34023631 DOI: 10.1016/j.clinph.2021.04.012  1
2021 Rusz J, Hlavnička J, Novotný M, Tykalová T, Pelletier A, Montplaisir J, Gagnon JF, Dušek P, Galbiati A, Marelli S, Timm PC, Teigen LN, Janzen A, Habibi M, Stefani A, ... ... Oertel W, et al. Speech biomarkers in rapid eye movement sleep behaviour disorder and Parkinson's disease. Annals of Neurology. PMID 33856074 DOI: 10.1002/ana.26085  1
2021 Perkins JE, Janzen A, Bernhard FP, Wilhelm K, Brien DC, Huang J, Coe BC, Vadasz D, Mayer G, Munoz DP, Oertel WH. Saccade, Pupil, and Blink Responses in Rapid Eye Movement Sleep Behavior Disorder. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33754406 DOI: 10.1002/mds.28585  1
2021 Lo C, Arora S, Ben-Shlomo Y, Barber TR, Lawton M, Klein JC, Kanavou S, Janzen A, Sittig E, Oertel WH, Grosset D, Hu MT. Olfactory Testing in Parkinson's Disease & REM Behavior Disorder: A Machine Learning Approach. Neurology. PMID 33627500 DOI: 10.1212/WNL.0000000000011743  1
2021 Titze-de-Almeida R, Titze-de-Almeida SS, Ferreira GG, Brito Silva AP, de Paula Brandão PR, Oertel WH, Schenck CH, Delgado Rodrigues RN. microRNA signatures in prodromal REM sleep behavior disorder and early Parkinson's disease as noninvasive biomarkers. Sleep Medicine. 78: 160-168. PMID 33444973 DOI: 10.1016/j.sleep.2020.12.012  0.01
2021 Mufti K, Yu E, Rudakou U, Krohn L, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Arnulf I, Hu MTM, Montplaisir JY, Gagnon JF, Desautels A, Dauvilliers Y, Gigli GL, ... ... Oertel W, et al. Novel Associations of and with Rapid Eye Movement Sleep Behavior Disorder. Neurology. PMID 33397775 DOI: 10.1212/WNL.0000000000011464  1
2020 Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, et al. Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder. Annals of Clinical and Translational Neurology. PMID 33321002 DOI: 10.1002/acn3.51269  1
2020 Henrich MT, Geibl FF, Lakshminarasimhan H, Stegmann A, Giasson BI, Mao X, Dawson VL, Dawson TM, Oertel WH, Surmeier DJ. Determinants of seeding and spreading of α-synuclein pathology in the brain. Science Advances. 6. PMID 33177086 DOI: 10.1126/sciadv.abc2487  1
2020 Mufti K, Rudakou U, Yu E, Krohn L, Ruskey JA, Asayesh F, Laurent SB, Spiegelman D, Arnulf I, Hu MTM, Montplaisir JY, Gagnon JF, Desautels A, Dauvilliers Y, Gigli GL, ... ... Oertel W, et al. Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33001463 DOI: 10.1002/mds.28318  1
2020 Holtbernd F, Romanzetti S, Oertel WH, Knake S, Sittig E, Heidbreder A, Maier A, Krahe J, Wojtala J, Dogan I, Schulz JB, Schiefer J, Janzen A, Reetz K. Convergent Patterns of Structural Brain Changes in Rapid-eye-movement Sleep Behavior Disorder and Parkinson's Disease. Sleep. PMID 32974664 DOI: 10.1093/sleep/zsaa199  1
2020 Kogan RV, Janzen A, Meles SK, Sittig E, Renken RJ, Gurvits V, Mayer G, Leenders KL, Oertel WH. Four-Year Follow-up of [ F]Fluorodeoxyglucose Positron Emission Tomography-Based Parkinson's Disease-Related Pattern Expression in 20 Patients With Isolated Rapid Eye Movement Sleep Behavior Disorder Shows Prodromal Progression. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32909650 DOI: 10.1002/Mds.28260  1
2020 Krohn L, Ruskey JA, Rudakou U, Leveille E, Asayesh F, Hu MTM, Arnulf I, Dauvilliers Y, Högl B, Stefani A, Monaca CC, Beatriz A, Plazzi G, Antelmi E, Ferini-Strambi L, ... ... Oertel W, et al. variants in REM sleep behavior disorder: a multicenter study. Neurology. PMID 32591474 DOI: 10.1212/Wnl.0000000000010042  1
2020 Han X, Wu P, Alberts I, Zhou H, Yu H, Bargiotas P, Yakushev I, Wang J, Höglinger G, Förster S, Bassetti C, Oertel W, Schwaiger M, Huang SC, Cumming P, et al. Characterizing the heterogeneous metabolic progression in idiopathic REM sleep behavior disorder. Neuroimage. Clinical. 27: 102294. PMID 32570206 DOI: 10.1016/J.Nicl.2020.102294  0.01
2020 Sipido KR, Antoñanzas F, Celis J, Degos L, Frackowiak R, Fuster V, Ganten D, Gay S, Hofstraat H, Holgate ST, Krestin G, Manns M, Meunier F, Oertel W, Palkonen S, et al. Overcoming fragmentation of health research in Europe: lessons from COVID-19. Lancet (London, England). PMID 32559417 DOI: 10.1016/S0140-6736(20)31411-2  1
2020 Tanner CM, Pahwa R, Hauser RA, Oertel WH, Isaacson SH, Jankovic J, Johnson R, Chernick D, Hubble J. EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson's Disease. Journal of Parkinson's Disease. PMID 31929122 DOI: 10.3233/JPD-191841  1
2019 Tilch E, Schormair B, Zhao C, Salminen AV, Antic Nikolic A, Holzknecht E, Högl B, Poewe W, Bachmann CG, Paulus W, Trenkwalder C, Oertel WH, Hornyak M, Fietze I, Berger K, et al. Identification of Restless Legs Syndrome Genes by Mutational Load Analysis. Annals of Neurology. PMID 31788832 DOI: 10.1002/Ana.25658  1
2019 Ganjam GK, Bolte K, Matschke LA, Neitemeier S, Dolga AM, Höllerhage M, Höglinger GU, Adamczyk A, Decher N, Oertel WH, Culmsee C. Mitochondrial damage by α-synuclein causes cell death in human dopaminergic neurons. Cell Death & Disease. 10: 865. PMID 31727879 DOI: 10.1038/s41419-019-2091-2  1
2019 Krämer HH, Lautenschläger G, de Azevedo M, Doppler K, Schänzer A, Best C, Oertel WH, Reuter I, Sommer C, Birklein F. Reduced central sympathetic activity in Parkinson's disease. Brain and Behavior. 9: e01463. PMID 31691543 DOI: 10.1002/brb3.1463  1
2019 Schweyer K, Rüschoff-Steiner C, Arias-Carrión O, Oertel WH, Rösler TW, Höglinger GU. Neuronal precursor cells with dopaminergic commitment in the rostral migratory stream of the mouse. Scientific Reports. 9: 13359. PMID 31527656 DOI: 10.1038/s41598-019-49920-5  1
2019 Wong YC, Luk K, Purtell K, Burke Nanni S, Stoessl AJ, Trudeau LE, Yue Z, Krainc D, Oertel W, Obeso JA, Volpicelli-Daley LA. Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31483900 DOI: 10.1002/Mds.27823  0.01
2019 Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, et al. Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31361367 DOI: 10.1002/Mds.27806  1
2019 Oertel WH, Henrich MT, Janzen A, Geibl FF. The locus coeruleus: Another vulnerability target in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 1423-1429. PMID 31291485 DOI: 10.1002/mds.27785  1
2019 Levin J, Maaß S, Schuberth M, Giese A, Oertel WH, Poewe W, Trenkwalder C, Wenning GK, Mansmann U, Südmeyer M, Eggert K, Mollenhauer B, Lipp A, Löhle M, Classen J, et al. Safety and efficacy of epigallocatechin gallate in multiple system atrophy (PROMESA): a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. PMID 31278067 DOI: 10.1016/S1474-4422(19)30141-3  1
2019 Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, ... ... Oertel WH, et al. How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30884545 DOI: 10.1002/Mds.27666  1
2019 Postuma RB, Iranzo A, Hu M, Högl B, Boeve BF, Manni R, Oertel WH, Arnulf I, Ferini-Strambi L, Puligheddu M, Antelmi E, Cochen De Cock V, Arnaldi D, Mollenhauer B, Videnovic A, et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain : a Journal of Neurology. PMID 30789229 DOI: 10.1093/Brain/Awz030  1
2019 Haas K, Stangl S, Steigerwald F, Matthies C, Gruber D, Kühn AA, Krauss JK, Sixel-Döring F, von Eckardstein K, Deuschl G, Classen J, Winkler D, Voges J, Galazky I, Oertel W, et al. Development of evidence-based quality indicators for deep brain stimulation in patients with Parkinson's disease and first year experience of implementation of a nation-wide registry. Parkinsonism & Related Disorders. PMID 30772278 DOI: 10.1016/J.Parkreldis.2019.01.016  1
2019 Arnaldi D, Meles SK, Giuliani A, Morbelli S, Renken RJ, Janzen A, Mayer G, Jonsson C, Oertel WH, Nobili F, Leenders KL, Pagani M. Brain Glucose Metabolism Heterogeneity in Idiopathic REM Sleep Behavior Disorder and in Parkinson's Disease. Journal of Parkinson's Disease. 9: 229-239. PMID 30741687 DOI: 10.3233/Jpd-181468  1
2019 Kübler D, Wächter T, Cabanel N, Su Z, Turkheimer FE, Dodel R, Brooks DJ, Oertel WH, Gerhard A. Widespread microglial activation in multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30726574 DOI: 10.1002/Mds.27620  0.01
2019 Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J. Reply to: A note on rotigotine for restless legs syndrome after renal transplantation. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 152-153. PMID 30653726 DOI: 10.1002/Mds.27570  1
2019 Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J. Reply to: Safety of dopamine agonists for treating restless legs syndrome. Movement Disorders : Official Journal of the Movement Disorder Society. 34: 150-151. PMID 30653723 DOI: 10.1002/Mds.27571  1
2019 Geibl FF, Henrich MT, Oertel WH. Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 126: 377-396. PMID 30643975 DOI: 10.1007/s00702-019-01970-9  1
2019 Becker A, Faßbender K, Oertel WH, Unger MM. A punch in the gut - Intestinal inflammation links environmental factors to neurodegeneration in Parkinson's disease. Parkinsonism & Related Disorders. 60: 43-45. PMID 30292735 DOI: 10.1016/j.parkreldis.2018.09.032  1
2018 Doppler K, Brockmann K, Sedghi A, Wurster I, Volkmann J, Oertel WH, Sommer C. Dermal Phospho-Alpha-Synuclein Deposition in Patients With Parkinson's Disease and Mutation of the Glucocerebrosidase Gene. Frontiers in Neurology. 9: 1094. PMID 30619053 DOI: 10.3389/Fneur.2018.01094  1
2018 Cesari M, Christensen JAE, Sixel-Döring F, Trenkwalder C, Mayer G, Oertel WH, Jennum P, Sorensen HBD. Validation of a new data-driven automated algorithm for muscular activity detection in REM sleep behavior disorder. Journal of Neuroscience Methods. 312: 53-64. PMID 30468824 DOI: 10.1016/j.jneumeth.2018.11.016  1
2018 Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... ... Oertel W, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431  1
2018 Cesari M, Christensen JAE, Kempfner L, Olesen AN, Mayer G, Kesper K, Oertel WH, Sixel-Döring F, Trenkwalder C, Sorensen HBD, Jennum P. Comparison of computerized methods for REM sleep without atonia detection. Sleep. PMID 30011023 DOI: 10.1093/sleep/zsy133  1
2018 Di Luca M, Nutt D, Oertel W, Boyer P, Jaarsma J, Destrebecq F, Esposito G, Quoidbach V. Towards earlier diagnosis and treatment of disorders of the brain. Bulletin of the World Health Organization. 96: 298-298A. PMID 29875510 DOI: 10.2471/BLT.17.206599  0.01
2018 Winkelmann J, Allen RP, Högl B, Inoue Y, Oertel W, Salminen AV, Winkelman JW, Trenkwalder C, Sampaio C. Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017). Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29756335 DOI: 10.1002/Mds.27260  1
2018 Henrich MT, Geibl FF, Lee B, Chiu WH, Koprich JB, Brotchie JM, Timmermann L, Decher N, Matschke LA, Oertel WH. A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson's disease-like pathology in neurons and glia. Acta Neuropathologica Communications. 6: 39. PMID 29747690 DOI: 10.1186/S40478-018-0541-1  1
2018 Ouled Amar Bencheikh B, Ruskey JA, Arnulf I, Dauvilliers Y, Monaca CC, De Cock VC, Gagnon JF, Spiegelman D, Hu MTM, Högl B, Stefani A, Ferini-Strambi L, Plazzi G, Antelmi E, Young P, ... ... Oertel W, et al. LRRK2 protective haplotype and full sequencing study in REM sleep behavior disorder. Parkinsonism & Related Disorders. PMID 29576439 DOI: 10.1016/J.Parkreldis.2018.03.019  1
2018 Matschke LA, Rinné S, Snutch TP, Oertel WH, Dolga AM, Decher N. Calcium-activated SK potassium channels are key modulators of the pacemaker frequency in locus coeruleus neurons. Molecular and Cellular Neurosciences. PMID 29524627 DOI: 10.1016/J.Mcn.2018.03.002  1
2018 Meles SK, Renken RJ, Janzen AHO, Vadasz D, Pagani M, Arnaldi D, Morbelli S, Nobili F, Mayer G, Leenders KL, Oertel WHO. The metabolic pattern of idiopathic REM sleep behavior disorder reflects early-stage Parkinson's disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 29476004 DOI: 10.2967/Jnumed.117.202242  1
2018 Chou KL, Stacy M, Simuni T, Miyasaki J, Oertel WH, Sethi K, Fernandez HH, Stocchi F. The spectrum of "off" in Parkinson's disease: What have we learned over 40 years? Parkinsonism & Related Disorders. PMID 29456046 DOI: 10.1016/J.Parkreldis.2018.02.001  0.01
2017 Müller-Rebstein S, Trenkwalder C, Ebentheuer J, Oertel WH, Culmsee C, Höglinger GU. Drug Safety Analysis in a Real-Life Cohort of Parkinson's Disease Patients with Polypharmacy. Cns Drugs. PMID 29139041 DOI: 10.1007/s40263-017-0478-0  1
2017 Schormair B, Zhao C, Bell S, Tilch E, Salminen AV, Pütz B, Dauvilliers Y, Stefani A, Högl B, Poewe W, Kemlink D, Sonka K, Bachmann CG, Paulus W, Trenkwalder C, ... Oertel WH, et al. Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: a meta-analysis. The Lancet. Neurology. 16: 898-907. PMID 29029846 DOI: 10.1016/S1474-4422(17)30327-7  1
2017 Wagner J, Vulinović F, Grünewald A, Unger MM, Möller JC, Klein C, Michel PP, Ries V, Oertel WH, Alvarez-Fischer D. Acylated and unacylated ghrelin confer neuroprotection to mesencephalic neurons. Neuroscience. PMID 28987508 DOI: 10.1016/j.neuroscience.2017.09.045  1
2017 Höllerhage M, Moebius C, Melms J, Chiu WH, Goebel JN, Chakroun T, Koeglsperger T, Oertel WH, Rösler TW, Bickle M, Höglinger GU. Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Scientific Reports. 7: 11469. PMID 28904388 DOI: 10.1038/S41598-017-11664-5  1
2017 Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28843021 DOI: 10.1002/mds.27105  1
2017 Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson's disease (EASE LID 3). Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28833562 DOI: 10.1002/mds.27131  1
2017 Hauser RA, Pahwa R, Tanner CM, Oertel W, Isaacson SH, Johnson R, Felt L, Stempien MJ. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson's Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study. Journal of Parkinson's Disease. PMID 28777755 DOI: 10.3233/JPD-171134  1
2017 Meles SK, Vadasz D, Renken RJ, Sittig-Wiegand E, Mayer G, Depboylu C, Reetz K, Overeem S, Pijpers A, Reesink FE, van Laar T, Heinen L, Teune LK, Höffken H, Luster M, ... ... Oertel WH, et al. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28734065 DOI: 10.1002/Mds.27094  1
2017 Trenkwalder C, Winkelmann J, Oertel W, Virgin G, Roubert B, Mezzacasa A. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Movement Disorders : Official Journal of the Movement Disorder Society. 32: 1478-1482. PMID 28643901 DOI: 10.1002/mds.27040  1
2017 Amara AW, Chahine LM, Caspell-Garcia C, Long JD, Coffey C, Högl B, Videnovic A, Iranzo A, Mayer G, Foldvary-Schaefer N, Postuma R, Oertel W, Lasch S, Marek K, Simuni T, et al. Longitudinal assessment of excessive daytime sleepiness in early Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 28554959 DOI: 10.1136/Jnnp-2016-315023  1
2017 Respondek G, Kurz C, Arzberger T, Compta Y, Englund E, Ferguson LW, Gelpi E, Giese A, Irwin DJ, Meissner WG, Nilsson C, Pantelyat A, Rajput A, van Swieten JC, Troakes C, ... ... Oertel WH, et al. Which ante mortem clinical features predict progressive supranuclear palsy pathology? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28500752 DOI: 10.1002/Mds.27034  1
2017 Höglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Müller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, ... ... Oertel WH, et al. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28467028 DOI: 10.1002/Mds.26987  1
2017 Oertel WH. Recent advances in treating Parkinson's disease. F1000research. 6: 260. PMID 28357055 DOI: 10.12688/f1000research.10100.1  0.01
2017 Doppler K, Jentschke HM, Schulmeyer L, Vadasz D, Janzen A, Luster M, Höffken H, Mayer G, Brumberg J, Booij J, Musacchio T, Klebe S, Sittig-Wiegand E, Volkmann J, Sommer C, ... Oertel WH, et al. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathologica. PMID 28180961 DOI: 10.1007/S00401-017-1684-Z  1
2017 Möller L, Kassubek J, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Pinkhardt EH, Respondek G, Stamelou M, Möller F, Schnitzler A, Oertel WH, Knake S, Huppertz HJ, et al. Manual MRI morphometry in Parkinsonian syndromes. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28150443 DOI: 10.1002/mds.26921  1
2017 Boura E, Stamelou M, Vadasz D, Ries V, Unger MM, Kägi G, Oertel WH, Möller JC, Mylius V. Is increased spinal nociception another hallmark for Parkinson's disease? Journal of Neurology. 264: 570-575. PMID 28120040 DOI: 10.1007/s00415-016-8390-y  1
2017 Lahut S, Gispert S, Ömür Ö, Depboylu C, Seidel K, Domínguez-Bautista JA, Brehm N, Tireli H, Hackmann K, Pirkevi C, Leube B, Ries V, Reim K, Brose N, den Dunnen WF, ... ... Oertel W, et al. Blood RNA biomarkers in prodromal PARK4 and REM sleep behavior disorder show role of complexin-1 loss for risk of Parkinson's disease. Disease Models & Mechanisms. PMID 28108469 DOI: 10.1242/Dmm.028035  1
2017 Lasser-Katz E, Simchovitz A, Chiu WH, Oertel WH, Sharon R, Soreq H, Roeper J, Goldberg JA. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 37: 47-57. PMID 28053029 DOI: 10.1523/Jneurosci.1079-16.2016  1
2016 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, Bloem BR, et al. Abolishing the 1-year rule: How much evidence will be enough? Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27666574 DOI: 10.1002/Mds.26796  1
2016 Sailer A, Scholz SW, Nalls MA, Schulte C, Federoff M, Price TR, Lees A, Ross OA, Dickson DW, Mok K, Mencacci NE, Schottlaender L, Chelban V, Ling H, O'Sullivan SS, ... ... Oertel W, et al. A genome-wide association study in multiple system atrophy. Neurology. PMID 27629089 DOI: 10.1212/Wnl.0000000000003221  1
2016 Sipido K, Degos L, Frackowiak R, Ganten D, Hofstraat H, Horvath I, Luyten F, Manns M, Oertel W, Zima T. Scientific Panel for Health: better research for better health. Lancet (London, England). 388: 865-6. PMID 27597458 DOI: 10.1016/S0140-6736(16)31426-X  1
2016 Oertel W, Schulz JB. Current and experimental treatments of Parkinson disease: A guide for neuroscientists. Journal of Neurochemistry. PMID 27577098 DOI: 10.1111/jnc.13750  0.01
2016 Rottscholl R, Haegele M, Jainsch B, Xu H, Respondek G, Höllerhage M, Rösler TW, Bony E, Le Ven J, Guérineau V, Schmitz-Afonso I, Champy P, Oertel WH, Yamada ES, Höglinger GU. Chronic consumption of Annona muricata juice triggers and aggravates cerebral tau phosphorylation in wild-type and MAPT transgenic mice. Journal of Neurochemistry. PMID 27569447 DOI: 10.1111/jnc.13835  1
2016 Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Berg D, Claßen J, Ebersbach G, et al. Erratum to: The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 27562771 DOI: 10.1007/s00702-016-1602-x  1
2016 Huppertz HJ, Möller L, Südmeyer M, Hilker R, Hattingen E, Egger K, Amtage F, Respondek G, Stamelou M, Schnitzler A, Pinkhardt EH, Oertel WH, Knake S, Kassubek J, Höglinger GU. Differentiation of neurodegenerative parkinsonian syndromes by volumetric magnetic resonance imaging analysis and support vector machine classification. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 27452874 DOI: 10.1002/mds.26715  1
2016 Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Medicine. 21: 1-11. PMID 27448465 DOI: 10.1016/J.Sleep.2016.01.017  1
2016 Heinzel S, Roeben B, Ben-Shlomo Y, Lerche S, Alves G, Barone P, Behnke S, Berendse HW, Bloem BR, Burn D, Dodel R, Grosset DG, Hu M, Kasten M, Krüger R, ... ... Oertel W, et al. Prodromal Markers in Parkinson's Disease: Limitations in Longitudinal Studies and Lessons Learned. Frontiers in Aging Neuroscience. 8: 147. PMID 27445791 DOI: 10.3389/Fnagi.2016.00147  1
2016 Oertel WH, Hallström Y, Saletu-Zyhlarz GM, Hopp M, Bosse B, Trenkwalder C. Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension. Cns Drugs. 30: 749-60. PMID 27401882 DOI: 10.1007/s40263-016-0372-1  1
2016 Schrempf W, Katona I, Dogan I, Felbert VV, Wienecke M, Heller J, Maier A, Hermann A, Linse K, Brandt MD, Reichmann H, Schulz JB, Schiefer J, Oertel WH, Storch A, et al. Reduced intraepidermal nerve fiber density in patients with REM sleep behavior disorder. Parkinsonism & Related Disorders. PMID 27318706 DOI: 10.1016/j.parkreldis.2016.06.003  1
2016 Lerche S, Heinzel S, Alves GW, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Bloem BR, Burn D, Dodel R, Grosset DG, Hipp G, Hu MT, Kasten M, Krüger R, ... ... Oertel W, et al. Aiming for Study Comparability in Parkinson's Disease: Proposal for a Modular Set of Biomarker Assessments to be Used in Longitudinal Studies. Frontiers in Aging Neuroscience. 8: 121. PMID 27303289 DOI: 10.3389/Fnagi.2016.00121  1
2016 Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, et al. The new definition and diagnostic criteria of Parkinson's disease. The Lancet. Neurology. 15: 546-8. PMID 27302120 DOI: 10.1016/S1474-4422(16)00116-2  1
2016 Bauer A, Cassel W, Benes H, Kesper K, Rye D, Sica D, Winkelman JW, Bauer L, Grieger F, Joeres L, Moran K, Schollmayer E, Whitesides J, Carney HC, Walters AS, ... Oertel W, et al. Rotigotine's effect on PLM-associated blood pressure elevations in restless legs syndrome: An RCT. Neurology. 86: 1785-93. PMID 27164714 DOI: 10.1212/Wnl.0000000000002649  1
2016 Oertel WH, Deuschl G, Eggert K. [The Competence Network Parkinson (CNP)]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. PMID 26961981 DOI: 10.1007/s00103-016-2312-0  1
2016 Stamelou M, Schöpe J, Wagenpfeil S, Del Ser T, Bang J, Lobach IY, Luong P, Respondek G, Oertel WH, Boxer A, Höglinger GU. Power calculations and placebo effect for future clinical trials in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26948290 DOI: 10.1002/mds.26580  1
2016 Levin J, Maaß S, Schuberth M, Respondek G, Paul F, Mansmann U, Oertel WH, Lorenzl S, Krismer F, Seppi K, Poewe W, Wenning G, Giese A, Bötzel K, et al. The PROMESA-protocol: progression rate of multiple system atrophy under EGCG supplementation as anti-aggregation-approach. Journal of Neural Transmission (Vienna, Austria : 1996). PMID 26809243 DOI: 10.1007/s00702-016-1507-8  1
2015 Mylius V, Ciampi de Andrade D, Cury RG, Teepker M, Ehrt U, Eggert KM, Beer S, Kesselring J, Stamelou M, Oertel WH, Möller JC, Lefaucheur JP. Pain in Parkinson's Disease: Current Concepts and a New Diagnostic Algorithm. Movement Disorders Clinical Practice. 2: 357-364. PMID 30363602 DOI: 10.1002/mdc3.12217  1
2015 Oertel W, Wichard T, Weissgerber A. Transformation of Ulva mutabilis (Chlorophyta) by vector plasmids integrating into the genome. Journal of Phycology. 51: 963-79. PMID 26986891 DOI: 10.1111/jpy.12336  0.01
2015 Hagge M, Nunnemann S, Bauer S, Gollwitzer S, Oertel WH, Knake S, Rosenow F, Hamer HM. Biceps electromyography in dialeptic and automotor seizures with and without secondary generalization. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. PMID 26596210 DOI: 10.1016/J.Clinph.2015.10.034  1
2015 Lerche S, Liepelt-Scarfone I, Alves G, Barone P, Behnke S, Ben-Shlomo Y, Berendse H, Burn D, Dodel R, Grosset D, Heinzel S, Hu M, Kasten M, Krüger R, Maetzler W, ... ... Oertel W, et al. Methods in Neuroepidemiology Characterization of European Longitudinal Cohort Studies in Parkinson's Disease - Report of the JPND Working Group BioLoC-PD. Neuroepidemiology. 45: 282-297. PMID 26523894 DOI: 10.1159/000439221  1
2015 Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, ... Oertel W, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431  1
2015 Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424  1
2015 Belke M, Heverhagen JT, Keil B, Rosenow F, Oertel WH, Stiasny-Kolster K, Knake S, Menzler K. DTI and VBM reveal white matter changes without associated gray matter changes in patients with idiopathic restless legs syndrome. Brain and Behavior. 5: e00327. PMID 26442748 DOI: 10.1002/Brb3.327  1
2015 Matschke LA, Bertoune M, Roeper J, Snutch TP, Oertel WH, Rinné S, Decher N. A concerted action of L- and T-type Ca(2+) channels regulates locus coeruleus pacemaking. Molecular and Cellular Neurosciences. 68: 293-302. PMID 26319746 DOI: 10.1016/J.Mcn.2015.08.012  1
2015 Riechmann J, Strzelczyk A, Reese JP, Boor R, Stephani U, Langner C, Neubauer BA, Oberman B, Philippi H, Rochel M, Seeger J, Seipelt P, Oertel WH, Dodel R, Rosenow F, et al. Costs of epilepsy and cost-driving factors in children, adolescents, and their caregivers in Germany. Epilepsia. 56: 1388-97. PMID 26235849 DOI: 10.1111/epi.13089  1
2015 Bach JP, Gold M, Mengel D, Hattesohl A, Lubbe D, Schmid S, Tackenberg B, Rieke J, Maddula S, Baumbach JI, Nell C, Boeselt T, Michelis J, Alferink J, Heneka M, ... Oertel W, et al. Measuring Compounds in Exhaled Air to Detect Alzheimer's Disease and Parkinson's Disease. Plos One. 10: e0132227. PMID 26168044 DOI: 10.1371/Journal.Pone.0132227  1
2015 Noelker C, Lu L, Höllerhage M, Vulinovic F, Sturn A, Roscher R, Höglinger GU, Hirsch EC, Oertel WH, Alvarez-Fischer D, Andreas H. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. Journal of the Neurological Sciences. 356: 129-36. PMID 26104567 DOI: 10.1016/j.jns.2015.06.030  1
2015 Simuni T, Caspell-Garcia C, Coffey C, Chahine LM, Lasch S, Oertel WH, Mayer G, Högl B, Postuma R, Videnovic A, Amara AW, Marek K. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1371-81. PMID 26095202 DOI: 10.1002/Mds.26248  1
2015 Höglinger GU, Alvarez-Fischer D, Arias-Carrión O, Djufri M, Windolph A, Keber U, Borta A, Ries V, Schwarting RK, Scheller D, Oertel WH. A new dopaminergic nigro-olfactory projection. Acta Neuropathologica. 130: 333-48. PMID 26072303 DOI: 10.1007/S00401-015-1451-Y  1
2015 Wiendl H, Elger C, Förstl H, Hartung HP, Oertel W, Reichmann H, Schwab S. Gaps Between Aims and Achievements in Therapeutic Modification of Neuronal Damage ("Neuroprotection"). Neurotherapeutics : the Journal of the American Society For Experimental Neurotherapeutics. 12: 449-54. PMID 25773662 DOI: 10.1007/S13311-015-0348-8  1
2015 Postuma RB, Iranzo A, Hogl B, Arnulf I, Ferini-Strambi L, Manni R, Miyamoto T, Oertel W, Dauvilliers Y, Ju YE, Puligheddu M, Sonka K, Pelletier A, Santamaria J, Frauscher B, et al. Risk factors for neurodegeneration in idiopathic rapid eye movement sleep behavior disorder: a multicenter study. Annals of Neurology. 77: 830-9. PMID 25767079 DOI: 10.1002/Ana.24385  1
2015 Depboylu C, Rösler TW, de Andrade A, Oertel WH, Höglinger GU. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease. Journal of Neurochemistry. 133: 590-7. PMID 25581060 DOI: 10.1111/jnc.13026  1
2015 Reese JP, Hamer H, Oertel WH, Strzelczyk A, Mueller UO, Heilmaier C, Kostev K. Association of time-to-levodopa with initial Parkinsonian medication: a retrospective cohort study. International Journal of Clinical Pharmacology and Therapeutics. 53: 107-14. PMID 25546160 DOI: 10.5414/CP202230  1
2015 Ferini-Strambi L, Oertel W, Dauvilliers Y, Postuma RB, Marelli S, Iranzo A, Arnulf I, Högl B, Manni R, Miyamoto T, Fantini ML, Puligheddu M, Jennum P, Sonka K, Santamaria J, et al. Erratum to: Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. Journal of Neurology. 262: 249-50. PMID 25504448 DOI: 10.1007/S00415-014-7609-Z  1
2014 Xu H, Rösler TW, Carlsson T, de Andrade A, Fiala O, Hollerhage M, Oertel WH, Goedert M, Aigner A, Höglinger GU. Tau silencing by siRNA in the P301S mouse model of tauopathy. Current Gene Therapy. 14: 343-51. PMID 25687501 DOI: 10.2174/156652321405140926160602  1
2014 Doss S, Wandinger KP, Hyman BT, Panzer JA, Synofzik M, Dickerson B, Mollenhauer B, Scherzer CR, Ivinson AJ, Finke C, Schöls L, Müller Vom Hagen J, Trenkwalder C, Jahn H, Höltje M, ... ... Oertel WH, et al. High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types. Annals of Clinical and Translational Neurology. 1: 822-32. PMID 25493273 DOI: 10.1002/Acn3.120  1
2014 Depboylu C, Klietz M, Maurer L, Oertel WH, Kobayashi K, Weihe E, Höglinger GU, Schäfer MK. Transcriptional and structural plasticity of tyrosine hydroxylase expressing neurons in both striatum and nucleus accumbens following dopaminergic denervation. Journal of Chemical Neuroanatomy. 61: 169-75. PMID 25451178 DOI: 10.1016/j.jchemneu.2014.10.003  1
2014 Höllerhage M, Deck R, De Andrade A, Respondek G, Xu H, Rösler TW, Salama M, Carlsson T, Yamada ES, Gad El Hak SA, Goedert M, Oertel WH, Höglinger GU. Piericidin A aggravates Tau pathology in P301S transgenic mice. Plos One. 9: e113557. PMID 25437199 DOI: 10.1371/Journal.Pone.0113557  1
Show low-probability matches.